These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

680 related items for PubMed ID: 10901156

  • 1. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
    Humble M.
    Acta Psychiatr Scand Suppl; 2000; 402():28-36. PubMed ID: 10901156
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological principles of antidepressant efficacy.
    Schatzberg AF.
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S17-22. PubMed ID: 12404665
    [Abstract] [Full Text] [Related]

  • 3. Antidepressant drugs: does it matter if they inhibit the reuptake of noradrenaline or serotonin?
    Eriksson E.
    Acta Psychiatr Scand Suppl; 2000 Jun; 402():12-7. PubMed ID: 10901154
    [Abstract] [Full Text] [Related]

  • 4. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.
    O'Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME, Lucki I.
    Psychopharmacology (Berl); 2007 Jun; 192(3):357-71. PubMed ID: 17318507
    [Abstract] [Full Text] [Related]

  • 5. Acute neural effects of selective serotonin reuptake inhibitors versus noradrenaline reuptake inhibitors on emotion processing: Implications for differential treatment efficacy.
    Outhred T, Hawkshead BE, Wager TD, Das P, Malhi GS, Kemp AH.
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1786-800. PubMed ID: 23886514
    [Abstract] [Full Text] [Related]

  • 6. The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects.
    Dell'Osso B, Palazzo MC, Oldani L, Altamura AC.
    CNS Neurosci Ther; 2011 Dec; 17(6):723-32. PubMed ID: 21155988
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.
    Miller HL, Delgado PL, Salomon RM, Berman R, Krystal JH, Heninger GR, Charney DS.
    Arch Gen Psychiatry; 1996 Feb; 53(2):117-28. PubMed ID: 8629887
    [Abstract] [Full Text] [Related]

  • 9. Pharmacology of antidepressants: selectivity or multiplicity?
    Westenberg HG.
    J Clin Psychiatry; 1999 Feb; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
    [Abstract] [Full Text] [Related]

  • 10. Augmentation strategies with serotonergic-noradrenergic combinations.
    Nelson JC.
    J Clin Psychiatry; 1998 Feb; 59 Suppl 5():65-8; discussion 69. PubMed ID: 9635550
    [Abstract] [Full Text] [Related]

  • 11. Duloxetine pharmacology: profile of a dual monoamine modulator.
    Karpa KD, Cavanaugh JE, Lakoski JM.
    CNS Drug Rev; 2002 Feb; 8(4):361-76. PubMed ID: 12481192
    [Abstract] [Full Text] [Related]

  • 12. The need for new and better antidepressants: reboxetine a new option.
    Dencker SJ.
    Acta Psychiatr Scand Suppl; 2000 Feb; 402():6-11. PubMed ID: 10901153
    [Abstract] [Full Text] [Related]

  • 13. Milnacipran and selective serotonin reuptake inhibitors in major depression.
    Lopez-Ibor J, Guelfi JD, Pletan Y, Tournoux A, Prost JF.
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Is there a role for a pure noradrenergic drug in the treatment of depression?
    Montgomery SA.
    Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S3-9; discussion S71-3. PubMed ID: 9169305
    [Abstract] [Full Text] [Related]

  • 16. The role of noradrenaline and selective noradrenaline reuptake inhibition in depression.
    Brunello N, Mendlewicz J, Kasper S, Leonard B, Montgomery S, Nelson J, Paykel E, Versiani M, Racagni G.
    Eur Neuropsychopharmacol; 2002 Oct; 12(5):461-75. PubMed ID: 12208564
    [Abstract] [Full Text] [Related]

  • 17. The neuropharmacology of serotonin and noradrenaline in depression.
    Nutt DJ.
    Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S1-12. PubMed ID: 12369606
    [Abstract] [Full Text] [Related]

  • 18. Noradrenergic versus serotonergic antidepressants: predictors of treatment response.
    Schatzberg AF.
    J Clin Psychiatry; 1998 Jun; 59 Suppl 14():15-8. PubMed ID: 9818626
    [Abstract] [Full Text] [Related]

  • 19. Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning.
    Dubini A, Bosc M, Polin V.
    J Psychopharmacol; 1997 Jun; 11(4 Suppl):S17-23. PubMed ID: 9438229
    [Abstract] [Full Text] [Related]

  • 20. Serotonergic and noradrenergic reuptake inhibitors: prediction of clinical effects from in vitro potencies.
    Frazer A.
    J Clin Psychiatry; 2001 Jun; 62 Suppl 12():16-23. PubMed ID: 11430614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.